Investor Alert

Company Close Updates Archives | Email alerts

Nov. 13, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slid 7.25% to $1.28 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.02% to 11,829.29 and the Dow Jones Industrial Average DJIA rising 1.37% to 29,479.81. Corbus Pharmaceuticals Holdings Inc. closed $8.50 below its 52-week high ($9.78), which the company reached on August 31st.

The stock underperformed when compared to some of its competitors Friday, as Fate Therapeutics Inc. FATE fell 2.83% to $50.51, Vanda Pharmaceuticals Inc. VNDA rose 1.74% to $13.17, and Viking Therapeutics Inc. VKTX remained unchanged. Trading volume (10.1 M) eclipsed its 50-day average volume of 6.2 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.